Skip to main content
Caplight Logo









Tasly Capital

Tasly Capital

Beijing, Beijingtasly.com

Overview

Tasly Capital is the corporate venture capital arm of Tasly Holding Group, established in 2008. Based in Beijing, China, the firm actively invests in the healthcare sector, with a focus on areas such as Oncology, Healthcare IT, and Diabetes. Its investment portfolio includes companies in China, Canada, and the United States.

Portfolio Companies

10

Website

tasly.com

Investments

Tasly Capital investments
CompanyDateStageLead
Hopstem BiotechnologyAug 2026Series CCo-investor
Hengsai BiotechnologyDec 2025StrategicLead
Shanghai UniXell BiotechnologyApr 2024Series ALead
Horimed Technology Co., Ltd.Mar 2024StrategicLead
Eureka BioFeb 2024Series BCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBeijing, Beijing
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?